All In MedTech

Device Trial Radar · NCT05685433

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

Last checked: Nov 20, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Jan 26, 2023

Primary completion

Apr 2028

Study completion Dec 2032

Sponsor

Lead sponsor
Valencia Technologies CorporationNot on our public-company list
Sponsor type
Industry
First posted
Jan 17, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).

Conditions

  • Overactive Bladder
  • Urge Incontinence
  • Incontinence, Urinary
  • Urinary Urge Incontinence

Interventions

  • eCoin Tibial Nerve StimulationDevice

    Subcutaneous stimulation of the tibial nerve using the eCoin device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Responder RateTime frame: 12 months
  2. Safety: 12 months rate of all device or procedure related AEs.Time frame: 12 months

Locations

22 sites in 1 country. Site status is shown where the registry gives one.

  • Urology Centers of Alabama

    Homewood, Alabama · Recruiting

  • USA Health

    Mobile, Alabama · Withdrawn

  • Arkansas Urology

    Little Rock, Arkansas · Recruiting

19 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.